article thumbnail

Mitigating Serious Fall Risks and Associated Costs and Injuries with AI-Driven Motion Sensor Technology

HIT Consultant

As a therapeutic tool, patients perform appropriate rehabilitative movements while AI/ML-enabled affixed motion sensors instantly and accurately “feedback” the movements using graphics and numerical display of information. Structured balance and gait tests are administered by the patient or caregiver to monitor for changes or trends.

article thumbnail

Trying and Sentencing Youth As Adults: Key Takeaways from Recent Petrie-Flom Center Event

Bill Of Health

Panelists discussed these topics during a recent webinar hosted by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics. When kids are transferred into the adult criminal justice system, opportunities for rehabilitation are significantly limited. They are not at all centered-on rehabilitation.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Legal Capacity and Persons with Disabilities’ Struggle to Reclaim Control over Their Lives

Bill Of Health

The Health Law, Policy, Bioethics, and Biotechnology Workshop provides a forum for discussion of new scholarship in these fields from the world’s leading experts. Though the Workshop is typically open to the public, it is not currently, due to the COVID-19 pandemic.

article thumbnail

Bioethics, Psychedelic Therapy Abuse, and the Risk of Ethics Washing

Bill Of Health

Dr. Devenot is also an affiliated researcher with Project on Psychedelics Law and Regulation (POPLAR) at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School. Neşe Devenot, PhD is a Senior Lecturer in the University Writing Program at the Johns Hopkins University.

article thumbnail

Can Doctors Objectively Quantify and Measure Pain?

HIT Consultant

Non-addiction medicine rehabilitation specialists are likely to adjust medications based on patients’ complaints and justify increasing dosages, secondary to inadequate pain control, attributing such scenarios to the development of tolerance or progression of the disease. Frank Fornari, Ph.D.,

Doctors 52